Shoichiro Tanaka

2.6k total citations
54 papers, 1.7k citations indexed

About

Shoichiro Tanaka is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shoichiro Tanaka has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 31 papers in Surgery and 23 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shoichiro Tanaka's work include Diabetes and associated disorders (33 papers), Pancreatic function and diabetes (21 papers) and Diabetes Management and Research (15 papers). Shoichiro Tanaka is often cited by papers focused on Diabetes and associated disorders (33 papers), Pancreatic function and diabetes (21 papers) and Diabetes Management and Research (15 papers). Shoichiro Tanaka collaborates with scholars based in Japan, United States and South Korea. Shoichiro Tanaka's co-authors include Tetsuro Kobayashi, Akira Shimada, Taro Maruyama, Takuya Awata, Kōji Nakanishi, John M. Menezes, Daniel C. Jupiter, Raman C. Mahabir, Eiji Kawasaki and Hiroshi Ikegami and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Shoichiro Tanaka

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoichiro Tanaka Japan 25 1.2k 928 707 282 209 54 1.7k
Zdenĕk Šumnı́k Czechia 26 1.2k 1.0× 734 0.8× 853 1.2× 354 1.3× 378 1.8× 120 2.0k
Stanislava Koloušková Czechia 23 736 0.6× 413 0.4× 531 0.8× 258 0.9× 337 1.6× 83 1.3k
Jyrki Jalkanen Finland 20 165 0.1× 477 0.5× 462 0.7× 179 0.6× 299 1.4× 48 1.8k
Pekka Ahonen Finland 10 521 0.4× 199 0.2× 797 1.1× 246 0.9× 93 0.4× 15 1.3k
Paul F. Gores United States 29 546 0.5× 1.6k 1.7× 433 0.6× 128 0.5× 269 1.3× 87 2.5k
Hiroshi Naganuma Japan 19 284 0.2× 344 0.4× 216 0.3× 88 0.3× 213 1.0× 43 1.6k
L. Bresler France 16 259 0.2× 683 0.7× 289 0.4× 36 0.1× 149 0.7× 75 1.3k
Emilian Snarski Poland 14 206 0.2× 251 0.3× 166 0.2× 121 0.4× 116 0.6× 42 806
Solange Grunenwald France 16 136 0.1× 164 0.2× 299 0.4× 293 1.0× 134 0.6× 49 922
A A M Lewis United Kingdom 16 322 0.3× 692 0.7× 85 0.1× 102 0.4× 83 0.4× 32 1.2k

Countries citing papers authored by Shoichiro Tanaka

Since Specialization
Citations

This map shows the geographic impact of Shoichiro Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichiro Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichiro Tanaka more than expected).

Fields of papers citing papers by Shoichiro Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichiro Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichiro Tanaka. The network helps show where Shoichiro Tanaka may publish in the future.

Co-authorship network of co-authors of Shoichiro Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Shoichiro Tanaka. A scholar is included among the top collaborators of Shoichiro Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoichiro Tanaka. Shoichiro Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimizu, Ryo, et al.. (2022). IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration. CEN Case Reports. 12(3). 270–274. 2 indexed citations
2.
Kobayashi, Tetsuro, Shoichiro Tanaka, & Kaoru Aida. (2020). Unique pathological changes in the pancreas of fulminant type 1 diabetes. Diabetology International. 11(4). 323–328. 7 indexed citations
3.
Tanaka, Yukari, Sachiko Iwata, Masahiro Kinoshita, et al.. (2017). Insufficient Humidification of Respiratory Gases in Patients Who Are Undergoing Therapeutic Hypothermia at a Paediatric and Adult Intensive Care Unit. Canadian Respiratory Journal. 2017. 1–6. 2 indexed citations
5.
Tanaka, Shoichiro, Sachiko Iwata, Masahiro Kinoshita, et al.. (2016). Use of Normothermic Default Humidifier Settings Causes Excessive Humidification of Respiratory Gases During Therapeutic Hypothermia. Therapeutic Hypothermia and Temperature Management. 6(4). 180–188. 3 indexed citations
6.
Kazama, Fuminori, Makoto Osada, Osamu Inoue, et al.. (2015). Measurement of soluble C-type lectin-like receptor 2 in human plasma. Platelets. 26(8). 711–719. 25 indexed citations
7.
Tanaka, Shoichiro, Minoru Okubo, Soichi Takizawa, et al.. (2015). Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM). Diabetology International. 7(1). 42–52. 15 indexed citations
8.
Tanaka, Shoichiro, et al.. (2015). Intracystic Biopsy and Diagnosis of Intraductal Papillary Mucinous Neoplasm via SpyGlass Pancreatoscopy.. PubMed. 15(4). 452–4. 4 indexed citations
9.
Baden, Megu Y., Akihisa Imagawa, Hiromi Iwahashi, et al.. (2015). Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitus. Diabetology International. 7(3). 281–288. 5 indexed citations
10.
Tanaka, Shoichiro, Raman C. Mahabir, Daniel C. Jupiter, & John M. Menezes. (2012). Updating the Epidemiology of Cleft Lip with or without Cleft Palate. Plastic & Reconstructive Surgery. 129(3). 511e–518e. 156 indexed citations
11.
Kobayashi, Tetsuro, Yoriko Nishida, Shoichiro Tanaka, & Kaoru Aida. (2011). Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin‐dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Diabetes/Metabolism Research and Reviews. 27(8). 965–970. 18 indexed citations
12.
Aida, Kaoru, Yoriko Nishida, Shoichiro Tanaka, et al.. (2011). RIG-I– and MDA5-Initiated Innate Immunity Linked With Adaptive Immunity Accelerates β-Cell Death in Fulminant Type 1 Diabetes. Diabetes. 60(3). 884–889. 63 indexed citations
13.
Awata, Takuya, Eiji Kawasaki, Hiroshi Ikegami, et al.. (2011). Analysis of the HLA and non‐HLA susceptibility loci in Japanese type 1 diabetes. Diabetes/Metabolism Research and Reviews. 27(8). 844–848. 28 indexed citations
14.
Haraguchi, Kazutaka, Shigeko Hara, Yoshifumi Ubara, et al.. (2009). Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function. Diabetes Research and Clinical Practice. 83(3). 295–299. 5 indexed citations
15.
Tanaka, Shoichiro, Yoriko Nishida, Kaoru Aida, et al.. (2009). Enterovirus Infection, CXC Chemokine Ligand 10 (CXCL10), and CXCR3 Circuit. Diabetes. 58(10). 2285–2291. 124 indexed citations
16.
Takamura, Toshinari, Masaru Sakurai, Hisakazu Shindo, et al.. (2008). New insulin sensitivity index from the oral glucose tolerance test. Diabetes Research and Clinical Practice. 79(1). 24–30. 13 indexed citations
18.
Ikegami, Hiroshi, Takuya Awata, Eiji Kawasaki, et al.. (2006). The Association ofCTLA4Polymorphism with Type 1 Diabetes Is Concentrated in Patients Complicated with Autoimmune Thyroid Disease: A Multicenter Collaborative Study in Japan. The Journal of Clinical Endocrinology & Metabolism. 91(3). 1087–1092. 78 indexed citations
19.
Hayakawa, Mikito, Minoru Okubo, Hideyuki Katori, et al.. (2002). A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy. American Journal of Kidney Diseases. 39(3). e15.1–e15.4. 7 indexed citations
20.
Tanaka, Shoichiro, et al.. (1974). [Induced hypothermia--progress and present status].. PubMed. 27(12). 1035–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026